FARDA BARANDEH: Open Payments
NPI 1588024954 · RESTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,505 in 117 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,554 · 2025 $2,505
Food & beverage: $2,505
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $505 |
| Janssen Biotech, Inc. | 14 | $450 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $275 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $234 |
| GENZYME CORPORATION | 8 | $204 |
| PFIZER INC. | 12 | $198 |
| Madrigal Pharmaceuticals | 3 | $186 |
| Lilly USA, LLC | 5 | $113 |
| Gilead Sciences, Inc. | 5 | $108 |
| QOL Medical, LLC | 3 | $67 |
Products named: TREMFYA, RINVOQ, ENTYVIO, XIFAXAN, DUPIXENT, REZDIFFRA, XELJANZ, OMVOH.
Industry payments across VA — which companies pay providers there.
